Effects of GABAB receptor positive allosteric modulator BHF177 and IRS‐1 on apoptosis of hippocampal neurons in rats with refractory epilepsy via the PI3K/Akt pathway
Authors:
- 21 August 2022
- journal article
- research article
- Published by Wiley in Cell Biology International
- Vol. 46 (11) , 1775-1786
Abstract
The present study was conducted to determine the effects of the γ‐aminobutyric acid B (GABAB) receptor positive allosteric modulator BHF177 on refractory epilepsy (RE). An RE rat model was initially established via treatment with lithium‐pilocarpine. The RE rats were then treated with BHF177 or the GABAB receptor antagonist CGP46381, followed by recording of their seizure rate and assessment of their spatial learning in the Morris water maze test. Treatment of BHF177 reduced the seizure intensity, whereas this effect was revered upoj treatment with CGP46381. Immunohistochemistry revealed that BHF177 treatment diminished P‐glycoprotein (P‐gp) expression in the hippocampal tissues of RE rats. Next, we found that BHF177 activated GABAB receptor, resulting in upregulated expression of insulin receptor substrate 1 (IRS‐1) and PI3K, as well as antiapoptotic factors (Bcl‐2 and mTOR), along with suppression of the apoptosis factors Bax and cleaved caspase‐3 in the hippocampal tissues. Further, activation of GABAB receptors by BHF177 alleviated the inflammatory response in hippocampal tissues of RE rats, as evidenced by reduced VCAM‐1, ICAM‐1, and tumor necrosis factor‐α levels. Next, we treated primary cultured rat hippocampal neurons with BHF177 and the IRS‐1 selective inhibitor NT157. BHF177 inhibited hippocampal apoptosis in rat hippocampal neurons by regulating the IRS‐1/PI3K/Akt axis through crosstalk between GABAB and insulin‐like growth factor‐1 receptors. Collectively, our findings indicate that the BHF177 inhibited neuron apoptosis, thus protecting against RE through the IRS‐1/PI3K/Akt axis, which may present a new therapeutic channel for RE.Keywords
This publication has 59 references indexed in Scilit:
- Comparison of the effects of the GABAB receptor positive modulator BHF177 and the GABAB receptor agonist baclofen on anxiety-like behavior, learning, and memory in miceNeuropharmacology, 2013
- Pentylenetetrazole‐induced seizures cause acute, but not chronic, mTOR pathway activation in ratEpilepsia, 2012
- Repeated administration of the GABAB receptor positive modulator BHF177 decreased nicotine self-administration, and acute administration decreased cue-induced reinstatement of nicotine seeking in ratsPsychopharmacology, 2010
- Proneurotrophins, Seizures, and Neuronal ApoptosisThe Neuroscientist, 2010
- GABABReceptor Activation Protects Neurons from Apoptosis via IGF-1 Receptor TransactivationJournal of Neuroscience, 2010
- Reduced hippocampal damage and epileptic seizures after status epilepticus in mice lacking proapoptotic PumaThe FASEB Journal, 2009
- Seizures in Patients with Multiple SclerosisCNS Drugs, 2009
- Neuroprotective efficacy and therapeutic window of curcuma oil: in rat embolic stroke modelBMC Complementary and Alternative Medicine, 2008
- Positive Modulation of GABAB Receptors Decreased Nicotine Self-Administration and Counteracted Nicotine-Induced Enhancement of Brain Reward Function in RatsThe Journal of Pharmacology and Experimental Therapeutics, 2008
- Epilepsy, Hyperalgesia, Impaired Memory, and Loss of Pre- and Postsynaptic GABAB Responses in Mice Lacking GABAB(1)Neuron, 2001